Physician profile
Susan Baker
NPI 1912901448
$14,377.10
in general payments reported to CMS, 2019-2025
39 companies · $1,598 in 2025
The $1,598 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,364 · 2020: $2,522 · 2021: $1,944 · 2022: $2,260 · 2023: $1,689 · 2024: $2,000 · 2025: $1,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,192 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,191.80 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,538.32 | 2019-2025 | Evenity, Otezla, Prolia |
| Abbvie INC. | $1,917.32 | 2019-2025 | Rinvoq, Skyrizi, Ubrelvy |
| Ucb, INC. | $1,686.71 | 2020-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $1,636.57 | 2019-2025 | Tremfya, Stelara, Remicade |
| Pfizer INC. | $1,073.35 | 2019-2023 | |
| Glaxosmithkline, LLC. | $912.94 | 2019-2025 | Benlysta |
| Lilly USA, LLC | $715.46 | 2019-2025 | Zepbound, Mounjaro |
| Mallinckrodt Hospital Products INC. | $487.69 | 2020-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $305.74 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $280.20 | 2021-2025 | Saphnelo |
| Mallinckrodt Enterprises LLC | $233.81 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.70 | 2023-2024 | Xifaxan |
| Celgene Corporation | $212.30 | 2019 | |
| Merck Sharp & Dohme LLC | $194.93 | 2019-2021 | |
| Genzyme Corporation | $190.44 | 2019-2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $187.54 | 2023-2024 | |
| Novo Nordisk INC | $163.34 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Bausch Health US, LLC | $135.06 | 2023-2025 | Aplenzin |
| Aurinia Pharma U.S., INC. | $132.72 | 2021-2025 | Lupkynis |
| Horizon Therapeutics Plc | $132.49 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $128.10 | 2020-2022 | |
| Bioventus LLC | $103.72 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $92.03 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.61 | 2019-2023 | Cyltezo |
| Ani Pharmaceuticals, INC. | $79.81 | 2024 | Purified Cortrophin Gel |
| Hikma Pharmaceuticals USA | $57.87 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $55.41 | 2019-2020 | |
| Eisai INC. | $52.83 | 2021-2024 | |
| Shield Therapeutics INC | $48.83 | 2023-2024 | Accrufer |
| Organon LLC | $42.02 | 2022 | |
| Fidia Pharma USA INC. | $40.90 | 2025 | Triluron, Hymovis |
| Ibsa Pharma INC. | $39.05 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $37.65 | 2023 | Seglentis, Livalo |
| Sobi, INC | $33.60 | 2024 | |
| Genentech USA, INC. | $29.41 | 2025 | Actemra |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.94 | 2022 | |
| Exact Sciences Corporation | $25.93 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $21.83 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.93 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.